首页 | 本学科首页   官方微博 | 高级检索  
检索        

金莲花颗粒联合头孢克肟治疗小儿急性呼吸道感染的临床研究
引用本文:曾学文,林烈桔,麦朗君.金莲花颗粒联合头孢克肟治疗小儿急性呼吸道感染的临床研究[J].现代药物与临床,2018,33(1):84-87.
作者姓名:曾学文  林烈桔  麦朗君
作者单位:儋州市人民医院 儿科, 海南 儋州 571751,儋州市人民医院 儿科, 海南 儋州 571751,儋州市人民医院 儿科, 海南 儋州 571751
摘    要:目的探讨金莲花颗粒联合头孢克肟治疗小儿急性呼吸道感染的临床疗效。方法选取儋州市人民医院2015年9月—2016年9月收治的急性呼吸道感染患儿176例,随机分成对照组和治疗组,每组各88例。对照组患儿口服头孢克肟颗粒,体质量≥30 kg患儿,100 mg/次,体质量30 kg患儿,3 mg/kg,2次/d;治疗组在对照组的基础上口服金莲花颗粒,每次1/3~1/2袋,3次/d。所有患儿均规律治疗5 d。观察两组患者临床疗效,比较治疗前后两组患儿IL-8、C反应蛋白(CRP)和降钙素原(PCT)水平以及主要临床症状消失时间和不良反应情况。结果治疗后,对照组临床总有效率为87.50%,显著低于治疗组的97.73%,两组比较差异具有统计学意义(P0.05)。治疗后,两组IL-8、CRP和PCT血清水平均较治疗前显著降低(P0.05);且治疗组IL-8、CRP和PCT水平明显低于对照组(P0.05)。治疗后,治疗组患儿体温恢复时间和咳嗽消失时间均显著短于对照组患儿,两组比较差异具有统计学意义(P0.05)。治疗期间,对照组不良反应发生率为12.50%,明显高于治疗组的3.41%,两组比较差异具有统计学意义(P0.05)。结论金莲花颗粒联合头孢克肟治疗小儿急性呼吸道感染疗效显著,安全性好,具有一定的临床推广应用价值。

关 键 词:金莲花颗粒  头孢克肟颗粒  急性呼吸道感染  临床疗效  C反应蛋白  降钙素原  不良反应
收稿时间:2017/10/27 0:00:00

Clinical study on Jinlianhua Granules combined with cefixime in treatment of acute respiratory tract infection in children
ZENG Xue-wen,LIN Lie-jie and MAI Lang-jun.Clinical study on Jinlianhua Granules combined with cefixime in treatment of acute respiratory tract infection in children[J].Drugs & Clinic,2018,33(1):84-87.
Authors:ZENG Xue-wen  LIN Lie-jie and MAI Lang-jun
Institution:Department of Pediatrics, Danzhou People''s Hospital, Danzhou 571751, China,Department of Pediatrics, Danzhou People''s Hospital, Danzhou 571751, China and Department of Pediatrics, Danzhou People''s Hospital, Danzhou 571751, China
Abstract:Objective To explore the clinical effect of Jinlianhua Granules combined with cefixime in treatment of acute respiratory tract infection in children. Methods Children (176 cases) with acute respiratory tract infection in Danzhou People''s Hospital from September 2015 to September 2016 were randomly divided into control and treatment groups, and each group had 88 cases. Children in the control group were po administered with Cefixime Granules, 100 mg/time for children weighed more than 30 kg, and 3 mg/kg for children weighed less than 30 kg, twice daily. Children in the treatment group were po administered with Jinlianhua Granules on the basis of the control group, 1/3-1/2 bag/time, three times daily. Children in two groups were treated for 5 d. After treatment, the clinical efficacy was evaluated, and IL-8, CRP and PCT levels, the disappearance time of main clinical symptoms, and adverse reaction in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control group was 87.50%, which was significantly lower than 97.73% in the treatment group, with significant difference between two groups (P < 0.05). After treatment, IL-8, CRP, and PCT levels in two groups were significantly decreased (P < 0.05). And the IL-8, CRP, and PCT levels in the treatment group were significantly lower than those in the control group (P < 0.05). After treatment, the temperature recovering time and coughing disappearance time in the treatment group were significantly shorter than those in the control group, with significant difference between two groups (P < 0.05). During the treatment, the incidence of adverse reactions in the control group was 12.50%, which was significantly higher than 3.41% in the treatment group, with significant difference between two groups (P < 0.05). Conclusion Jinlianhua Granules combined with cefixime has significant effect in treatment of acute respiratory tract infection in children with high safety, which has a certain clinical application value.
Keywords:Jinlianhua Granules  Cefixime Granules  acute upper respiratory tract infection  clinical efficacy  CRP  PCT  adverse reaction
本文献已被 CNKI 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号